Evogene Ltd. (EVGN)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
|
Mr. Ofer Haviv CPA
|
CEO, President, CFO & Director | 423k | -- | 1966 |
|
Mr. Yoash Zohar
|
Chief Executive Officer of Casterra Ag Ltd. | 251k | -- | 1967 |
|
Dr. Dan Jacob Gelvan Ph.D.
|
Chief Executive Officer of Ag Plenus Ltd. | 210k | -- | 1964 |
|
Dr. Ilia Zhidkov
|
Chief Technology Officer | -- | -- | 1977 |
|
Ms. Liat Foigel Wejgman
|
Vice President of Human Resources | -- | -- | -- |
|
Dr. Gabi Tarcic Ph.D.
|
Chief Development Officer | -- | -- | 1980 |
Evogene Ltd.
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 38
Description
Evogene Ltd., together with its subsidiaries, operates as a computational biology company in Israel, the United States, Europe, and Africa. It operates through three segments: Agriculture, Human Health, and Industrial Applications. The company engages in the agricultural activities, including seed traits and ag-chemicals activities; and design novel small molecules for drug development by utilizing ChemPass AI, a computational generative AI engine. It also focuses on the development and commercialization of castor bean seeds for industrial uses. In addition, the company medical cannabis products. It has a collaboration with LMU University Hospital Munich to develop novel therapies for hyper-inflammatory diseases driven by dysregulated neutrophil activity, including inflammatory bowel disease (IBD); and with ELEO, Inc. to develop oral small-molecule inhibitors targeting the PCSK9 pathway for the treatment of hyperlipidemia and cardiovascular diseases. The company was incorporated in 1999 and is headquartered in Rehovot, Israel.
Corporate Governance
Upcoming Events
November 19, 2026 at 1:30 PM UTC
Evogene Ltd. Earnings Date
